To compare the ability of TBR-760 to arrest aggressive pituitary tumor growth in the POMC KO mouse model vs its individual SST or DA components, either alone or in combination, heterozygous POMC KO mice were again randomly assigned to treatment groups when they presented with tumors approximately 10 mm3 in size as determined by MRI. This evidence concerns the gene POMC and pituitary tumor.